Welcome Remarks
Alan Donnelly, Convenor of The G20 Health and Development Partnership
Ali Aslan, International TV Presenter, Moderator and Journalist
Keynotes
Ambassador Katharina Stasch, German Ambassador to the UN and other International Organizations
Febrian Ruddyard, Permanent Representative of Indonesia to the United Nations Office, Geneva
Fireside chat: In Conversation with…
Soumya Swaminathan, Chief Scientist, WHO
Stephen Twigg, Secretary General, Commonwealth Parliamentary Association
Panel 1
Digital Health – a fundamental pillar to strengthen the global health architecture
Lakshmi Balachandran, Senior Director, Digital Health, Clinton Health Access Initiative, Inc.
Alain B. Labrique, Director Digital Health, World Health Organization, WHO
Rajendra Pratap Gupta, Chairman, Dynamic Coalition on Digital Health, Internet Governance Forum
Giorgio Moretti, Founder and Chairman, Dedalus Group
Annalisa Pawlosky, Senior Research Analyst, Google
Omar Najim, Director, Executive Affairs Office, Abu Dhabi Department of Health
Bert Hartog, R&D Operations, Senior Director, Clinical Innovation, Janssen
Tamer H. Farag, Health Partner Innovation, Meta
Panel 2
What are the global best practice initiatives developed in G7, G20 and beyond during the pandemic? How can we make them more sustainable and strengthen efficient multilateral cooperation?
Thomas Cueni, Director General, IFPMA
Bill Rodriguez, CEO, FIND
Janet Ginnard, Head of Strategy, Unitaid
Saleh Al Ali, Executive Director, Emergency Centre, Department of Health Abu Dhabi
Marie-Ange Saraka-Yao, Managing Director and Director of Resource Mobilization, private Sector Partnerships, Innovative Finance Department, Gavi
Osamu Kunii, Chief Executive Officer, Global Health Innovative Technology Fund
Johan Vekemans, Senior Science and Clinical Advisor, IAVI
Lunch and Exhibition of G20HDP Partners on their work during COVID-19
Panel 3
Strengthening the global health architecture in the aftermath of COVID-19
Petro Terblanche, Managing Director, Afrigen Biologics
Philippe Francois, Senior Vice President, Global Supply, Becton, Dickinson and Company
Najat Mokhtar, Deputy Director General of Nuclear Science and Application, International Atomic Energy Agency, IAEA
Pierre Delsaux, Director-General, DG HERA
Sulaiman Saleh Al-Dakheel, General Manager, Gulf Health Council
Etleva Kadilli, Director Supply Division, UNICEF
Charles Gore, Executive Director, Medicines Patent Pool
David Reddy, CEO Medicines for Malaria Venture (MMV); Member of the Board, Coalition for Epidemic Preparedness Innovations, CEPI
Fireside chat
The two big killers worldwide – cardiovascular diseases and tuberculosis
Nick Herbert (Lord Herbert of South Downs), Chairman Global TB Caucus, Member House of Lords
Lucica Ditiu, Executive Director, Stop TB Partnership
Peter Krustrup, Professor of Sport and Health Sciences, University of Southern Denmark
Ricardo Baptista Leite, Founder and President, UNITE
Panel 4
Why is cardiovascular disease the number one killer worldwide despite being preventable?
Téa Collins, Lead, Global NCD Platform, Office of the Deputy Director-General, World Health Organization
Haseeb Ahmad, President Europe, Novartis
Kausik Ray, Professor of Public Health, Imperial College
Mathias Egermark, Senior Vice President Cardiometabolic Diseases Area Network, Roche Diagnostics
Dr Bente Mikkelsen, Director, WHO Department of Noncommunicable Diseases
Rifat Atun, Professor Harvard University, School of Public Health
Hasbullah Thabrany, Lead Co-Chair, Global Health Security and COVID-19 Task Force, T20 Indonesia
Panel 5
Where is AMR within the restructuring of the global health architecture?
Hanan Balkhy, Assistant Director General, Antimicrobial Resistance, WHO
Najat Mokhtar, Deputy Director General of Nuclear Science and Application, International Atomic Energy Agency, IAEA
Adam Zerda, Senior Director, International Affairs Becton, Dickinson and Company (BD)
Henry Skinner, CEO, AMR Action Fund
Kevin Outterson, Executive Director, Carb-X
Marc Gitzinger, CEO and Co-Founder, BioVersys
James Anderson, Executive Director, Global Health, IFPMA
Concluding remarks and outlook to G20 health ministers meeting